Image Image Image Image Image Image Image Image Image Image
Идти наверх

Идти наверх


· 03/10/2018

Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema

EMD_OCT negre

· 03/10/2018

THR-317-002: Clinical trial for the treatment of Diabetic Macular Oedema


· 01/10/2018

Clinical Trial OAKS and DERBY: Efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD


· 10/05/2018

Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease


· 28/07/2017

Geographic atrophy phenotype identification by cluster analysis

Fig 01 ooze

· 24/04/2017

Drusen Ooze: A Novel Hypothesis in Geographic Atrophy


· 30/08/2016

A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate

neovascularització coroidal

· 06/04/2016

Feeder vessel laser photocoagulation for idiopathic, subfoveal polypoidal choroidal vasculopaty not responding to eithelial growth factor therapy or photodynamic therapy

Direct Visualization of a New Choroidal Vessel...

· 06/04/2016

Direct Visualization of a New Choroidal Vessel on Spectral-Domain Optical Coherence Tomography

Foto Proxima A

· 31/03/2016

Proxima A (GX29633)

FOTO Proxima B

· 31/03/2016

Proxima B: (GX29639)

· 30/03/2016

Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.

· 30/03/2016

Correspondence. Wedge-Shaped Subretinal hyporeflectivity in GA.

· 17/02/2016

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.

· 21/10/2015

Scheduled versus Pro Re Nata Dosing in the VIEW Trials.

Last modified: 10 December, 2018 - 16:20